Fidelity Investments’s Sanara MedTech SMTI Stock Holding History

Fidelity Investments’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.3K	Sell	892 -738	-45%	-$15.2K	﹤0.01%	4618
2025 Q4	$38.1K	Buy	1,630 +1,363	+510%	+$35.2K	﹤0.01%	4219
2025 Q3	$8.47K	Sell	267 -213	-44%	-$6.43K	﹤0.01%	4654
2025 Q2	$13.6K	Buy	480 +320	+200%	+$9.6K	﹤0.01%	4432
2025 Q1	$4.94K	Sell	160 -97	-38%	-$3.29K	﹤0.01%	4710
2024 Q4	$8.53K	Buy	257 +86	+50%	+$2.92K	﹤0.01%	4516
2024 Q3	$5.17K	Buy	171 +9	+6%	+$281	﹤0.01%	4621
2024 Q2	$4.57K	Sell	162 -149	-48%	-$4.68K	﹤0.01%	4566
2024 Q1	$11.5K	Buy	311 +25	+9%	+$935	﹤0.01%	4225
2023 Q4	$11.8K	Sell	286 -267	-48%	-$8.57K	﹤0.01%	4186
2023 Q3	$17.2K	Buy	+553	New	+$21.4K	﹤0.01%	3883
2021 Q4	–	Sell	-68,215	Closed	-$2.32M	–	4880
2021 Q3	$2.32M	Buy	+68,215	New	+$2.45M	﹤0.01%	2536
2021 Q1	–	Sell	-50	Closed	-$2K	–	4490
2020 Q4	$2K	Buy	+50	New	+$1.97K	﹤0.01%	3612

Other funds holding SMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Fidelity Investments's SMTI Position: Q1 2026 in Review

Fidelity Investments reduced its Sanara MedTech (SMTI) stake by 45% in Q1 2026, selling an estimated $15.2K and leaving 892 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4618.

Fidelity Investments first reported a position in SMTI in Q4 2020 and has held it in 13 quarters since. The position peaked at $2.32M in Q3 2021. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.

Fidelity Investments held 892 shares of Sanara MedTech worth $15.3K as of Q1 2026.
Fidelity Investments sold 738 Sanara MedTech shares in Q1 2026, an estimated $15.2K.
Sanara MedTech made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #4618 holding.
Fidelity Investments first reported a position in Sanara MedTech in Q4 2020 and has held it in 13 quarters since.
Fidelity Investments's Sanara MedTech position peaked at $2.32M in Q3 2021.
65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.